The Effect of Interleukin-6 Gene Polymorphism on Pediatric Pneumonia

The Effect of Interleukin-6 Gene Polymorphism on Pediatric Pneumonia

Background: To investigate the effect of interleukin-6 (IL-6) gene polymorphism on pediatric pneumonia. Methods: Overall, 438 patients with pediatric pneumonia (Observation group) treated in Xuzhou Children Hospital, Cinna from July 2013 to July 2018 were randomly enrolled. Meanwhile, 423 health...

Full description

Bibliographic Details
Main Authors:	Guode SU, Lili DING, Zhenkun ZHANG
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2019-11-01
Series:	Iranian Journal of Public Health
Subjects:	Interleukin-6 Gene polymorphism Pediatric pneumonia Community acquired pneumonia
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/18846

Similar Items

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
by: Ilija Andrijevic, et al.
Published: (2014-01-01)

Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes
by: Tripon Raluca Elena, et al.
Published: (2019-04-01)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
by: Merida-Vieyra J, et al.
Published: (2019-04-01)

IL-8 CHEMOTACTIC FACTOR IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND FEATURES OF IL-8 GENE POLYMORPHISM (251 T/А)
by: L. F. Aznabaeva, et al.
Published: (2014-07-01)

IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients
by: M.R. Bacci, et al.
Published: (2015-05-01)

Evaluation of the significance of interleukin-6 in the diagnosis of postoperative pneumonia: a prospective study
by: Chen, W., et al.
Published: (2022)

Characterization of children younger than 5 Years of age with severe community-acquired alveolar pneumonia (CAAP) requiring Pediatric Intensive Care Unit (PICU) admission
by: Yael Feinstein, et al.
Published: (2020-08-01)

Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
by: Lumin Chen, et al.
Published: (2021-04-01)

Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan
by: Hsin Chi, et al.
Published: (2020-10-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

Contributions to an understanding of community-acquired pneumonia
by: Feldman, Charles
Published: (2010)

The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia
by: Jie Zhao, et al.
Published: (2020-05-01)

An Approach to Pneumonia in Immunocompetent Patients
by: Spandana Veeravalli, et al.
Published: (2021-06-01)

A 6-year Retrospective Epidemiologic Study of Pediatric Pneumococcal Pneumonia in Taiwan
by: Yi-Chuan Huang, et al.
Published: (2008-12-01)

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia
by: Rebecca G. Wallihan, et al.
Published: (2018-10-01)

Management of community-acquired pneumonia in infants and children: Clinical practice guidelines endorsed by the Saudi Pediatric Infectious Diseases Society
by: Omar Alzomor, et al.
Published: (2017-12-01)

Contributions to an understanding of community-acquired pneumonia
by: Feldman, Charles
Published: (2012)

chlamydia pneumoniae unfection in - patients with community acquired pneumonia in Iraq
by: hayfaa D. Salman
Published: (2009-01-01)

Case of severe Friedlander′s pneumonia with review of the literature
by: Prasanna K Satpathy, et al.
Published: (2014-01-01)

THE ROLE OF TUMOR NECROSIS FACTOR-α G–308A, INTERLEUKIN-1β C–511T AND INTERLEUKIN-10 G–1082A GENE POLYMORPHISMS IN THE DEVELOPMENT OF SLOWLYRESOLVED COURSE OF COMMUNITY-ACQUIRED PNEUMONIA
by: V. I. Sovalkin, et al.
Published: (2013-12-01)

Can Serum Surfactant Protein D Levels be used as an Effective Factor Instead of Clinical Severity Scores of Pneumonia in Pediatric Emergency Departments?
by: Mehmet Açıkgöz, et al.
Published: (2016-03-01)

Тhe features of severe community acquired pneumonia.
by: I. V. Avramenko
Published: (2015-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

Defining Community-Acquired Pneumonia as a Public Health Threat: Arguments in Favor from Spanish Investigators
by: Catia Cillóniz, et al.
Published: (2020-01-01)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
by: Sanath Thushara Kudagammana, et al.
Published: (2020-08-01)

Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children
by: Zhao J, et al.
Published: (2020-03-01)

PES Pathogens in Severe Community-Acquired Pneumonia
by: Catia Cillóniz, et al.
Published: (2019-02-01)

Características clínicas y epidemiológicas de las neumonías adquiridas en la comunidad por Mycoplasma pneumoniae en una población española, 2010-2015
by: David Aguilera-Alonso, et al.
Published: (2019-07-01)

Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ
by: Zobel Katrin, et al.
Published: (2012-02-01)

Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China
by: Zhuoxin Liang, et al.
Published: (2021-01-01)

A compendium for Mycoplasma pneumoniae
by: Gretchen Lynn Parrott, et al.
Published: (2016-04-01)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
by: Catia Cillóniz, et al.
Published: (2018-04-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: A. V. Martynova, et al.
Published: (2014-06-01)

Detection of IgM and IgG antibodies to Chlamydophila pneumoniae in pediatric community-acquired lower respiratory tract infections
by: Surinder Kumar, et al.
Published: (2011-01-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Use of medications in children hospitalized with community-acquired pneumonia
by: D. D. Siukaeva, et al.
Published: (2018-11-01)

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials
by: Thomas W. L. Scheeren, et al.
Published: (2019-02-01)

The epidemiology of hospital death following pediatric severe community acquired pneumonia
by: Xiao-Xiao Ao
Published: (2021-02-01)